Recommendations for the Treatment of Children With Burkitt's Lymphoma

Clinical Editorial

Official title: Recommendations for the Treatment of Children With Burkitt's Lymphoma

Summary: This is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP). The study hopes to be able to evaluate children earlier with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for the stage IV disease.

Conditions: Burkitt Lymphoma

Study type: OBSERVATIONAL

Enrollment: 1000 (ESTIMATED)

Status: RECRUITING

Completion: 2030-12-31 (ESTIMATED)

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT04425421

Open Original Source More Feed Items

Related by Condition/Drug

CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma: Summary and Missing Source Details

Infectious Disease • 24 Jul 2026

Role of splenectomy in Wiskott–Aldrich syndrome amid HSCT and gene therapy advances

Infectious Disease • 22 Jul 2026

ClinicalTrialsRelated by Conditionlymphoma

Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity

Infectious Disease • 12 Mar 2026

ClinicalTrialsRelated by Conditionlymphoma

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Infectious Disease • 05 Feb 2026

BMJ OpenRelated by Conditionlymphoma

Cancer epidemiology in Khyber Pakhtunkhwa, Pakistan (2020–2023): incidence counts and ASIRs

Oncology • 22 Jul 2026